Biocompatibility of biomedical energization elements

US2016056417A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016056417-A1
Application numberUS-201514827589-A
CountryUS
Kind codeA1
Filing dateAug 17, 2015
Priority dateAug 21, 2014
Publication dateFeb 25, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Designs, strategies and methods to improve biocompatibility of energization elements are described. In some examples, the biocompatible energization elements may be used in a biomedical device. In some further examples, the biocompatible energization elements may be used in a contact lens.

First claim

Opening claim text (preview).

What is claimed is: 1 . A biomedical device comprising: an electroactive component; a biocompatible battery, wherein the biocompatible battery comprises: a first and second current collector; a cathode; an anode; and a laminar structure, wherein at least a layer of the laminar structure has a volume removed to form a cavity, wherein the cavity contains an electrolyte solution, a separator, and the cathode; and wherein the biocompatibility of the biomedical device is improved by formulating a composition of the electrolyte solution to approximate a composition of biofluids in contact with the biomedical device. 2 . The biomedical device of claim 1 wherein the composition of the electrolyte solution approximates a composition of tear fluid. 3 . The biomedical device of claim 1 wherein a thickness of the biocompatible battery is less than 1 mm at least along a first dimension of an extent of the biocompatible battery. 4 . The biomedical device of claim 1 wherein a thickness of the biocompatible battery is less than 500 microns at least along a first dimension of an extent of the biocompatible battery. 5 . The biomedical device of claim 1 wherein a thickness of the biocompatible battery is less than 250 microns at least along a first dimension of an extent of the biocompatible battery. 6 . A biomedical device comprising: an electroactive component; a biocompatible battery, wherein the biocompatible battery comprises: a first and second current collector; a cathode; an anode; and a laminar structure, wherein at least a layer of the laminar structure has a volume removed to form a cavity, wherein the cavity contains an electrolyte solution, a separator, and the cathode; and wherein the biocompatibility of the biocompatible battery is improved by formulating a composition of the electrolyte solution to comprise a zinc salt at less than or approximately equal to 10 percent by weight. 7 . The biomedical device of claim 6 , wherein the biocompatible battery further comprises: a sealed encapsulation of the laminar structure, wherein the sealed encapsulation improves the biocompatibility of the biomedical device by decreasing an effusion of the electrolyte to an external environment. 8 . The biomedical device of claim 6 , wherein the biocompatible battery further comprises: a sealed encapsulation of the laminar structure, wherein the sealed encapsulation improves the biocompatibility of the biocompatible battery by decreasing an effusion of water into an internal environment of the biocompatible battery. 9 . The biomedical device of claim 6 further comprising: an encapsulating layer of hydrogel. 10 . The biomedical device of claim 9 wherein the encapsulating layer comprises the hydrogel which comprises zwitterions. 11 . A method of improving biocompatibility in a battery comprising: preparing an electrolyte solution; wherein the electrolyte solution comprises a zinc salt at a concentration less than or approximately equal to 10 percent by weight; obtaining a layer of a laminar structure; cutting out a volume from the layer of the laminar structure, wherein removing the volume from the layer of the laminar structure forms at least a portion of a cavity; and adding the electrolyte solution, a separator, an anode, an anode current collector, a cathode, and a cathode current collector, to form a biocompatible battery. 12 . The method of claim 11 further comprising forming a seal of an envelope layer to the laminar structure. 13 . The method of claim 11 further comprising forming a seal of a first envelope layer to a second envelope layer. 14 . The method of claim 13 wherein a total thickness of the biocompatible battery is less than 500 microns. 15 . A method of improving biocompatibility in a contact lens comprising: preparing an electrolyte solution; wherein the electrolyte solution comprises contact lens packaging solution; obtaining a layer of a laminar structure; cutting out a volume from the layer of the laminar structure, wherein removing the volume from the layer of the laminar structure forms at least a first portion of a cavity; adding the electrolyte solution, a separator, an anode, an anode current collector, a cathode, and a cathode current collector, to form the laminar structure; forming a seal of a first envelope layer to a second envelope layer, wherein the first envelope layer and the second envelope layer surround at least a second portion of the laminar structure; connecting the anode current collector to an electroactive device; connecting the cathode current collector to the electroactive device; and encapsulating the laminar structure and electroactive device in a hydrogel to form an ophthalmic device. 16 . The method of claim 15 wherein a total thickness of the laminar structure is less than 500 microns. 17 . The method of claim 15 wherein the hydrogel incorporates zwitterions. 18 . A method of improving biocompatibility in a contact lens comprising: preparing an electrolyte solution; obtaining a layer of a laminar structure; cutting out a volume from the layer of the laminar structure, wherein removing the volume from the layer of the laminar structure forms at least a first portion of a cavity; adding the electrolyte solution, a separator, an anode, an anode current collector, a cathode, and a cathode current collector, to form the laminar structure; forming a seal of a first envelope layer to a second envelope layer, wherein the first envelope layer and the second envelope layer surround at least a second portion of the laminar structure; connecting the anode current collector to an electroactive device; connecting the cathode current collector to the electroactive device; and encapsulating the laminar structure and electroactive device in a hydrogel to form an ophthalmic device. 19 . The method of claim 18 wherein a total thickness of the laminar structure is less than 500 microns. 20 . The method of claim 19 wherein the hydrogel incorporates zwitterions.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016056417A1 cover?
Designs, strategies and methods to improve biocompatibility of energization elements are described. In some examples, the biocompatible energization elements may be used in a biomedical device. In some further examples, the biocompatible energization elements may be used in a contact lens.
Who is the assignee on this patent?
Johnson & Johnson Vision Care
What technology area does this patent fall under?
Primary CPC classification H01M10/26. Mapped technology areas include Electricity.
When was this patent published?
Publication date Thu Feb 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).